logo
People turning to pharmacists for medical advice due to GP delays, research shows

People turning to pharmacists for medical advice due to GP delays, research shows

BreakingNews.ie14-07-2025
More people are turning to their local pharmacist for medical advice as they struggle to get a doctor's appointment.
Research by the Irish Pharmacy Union also shows nine in 10 think pharmacists should be allowed to prescribe medication for minor illnesses, such as back pain and migraines.
Advertisement
The survey of 2,000 people found nearly four-in-five are now waiting longer to get an appointment with their GP.
Meanwhile, figures from the Irish Nurses and Midwives Organisation (INMO) show there are 364 patients on trolleys on Monday morning.
226 patients are waiting in the emergency department, while 138 are in wards elsewhere in hospitals.
The hospital with the highest number of patients without a bed is University Hospital Limerick, with 83 people waiting for a bed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Review of child hip surgery cases won't begin until January, HSE confirms
Review of child hip surgery cases won't begin until January, HSE confirms

BreakingNews.ie

time18 minutes ago

  • BreakingNews.ie

Review of child hip surgery cases won't begin until January, HSE confirms

A review of the individual cases of children who may have undergone unnecessary hip surgeries will not take place until January, the HSE has confirmed. It comes after a clinical audit of surgeries for dysplasia of the hips in children found that a lower threshold for operations was used at CHI Temple Street hospital and the National Orthopaedic Hospital Cappagh (NOHC) than the threshold used at CHI Crumlin. Advertisement The review discovered that in the period 2021 to 2023, almost 80 per cent of children operated on at the NOHC, and 60 per cent of those at Temple Street, did not meet the threshold for surgery. In a statement, the HSE said an expert review is being commissioned and the independent panel will be convened to review patient files 'to determine, in so far as possible, the appropriateness of the original decision to operate in individual cases'. It said this would be based on the 'appropriate radiological indices and clinical history' of the cases. An international call for experts to apply for the panel closed on Friday and saw submissions from Ireland, the UK, the US, Canada, Asia, and other parts of Europe. Advertisement The HSE said these submissions will be subject to a shortlisting and recruitment process prior to the formal announcement of the panel, which is expected to convene in September. It is also negotiating terms and conditions for an independent international expert to chair the panel who has already been identified, adding that their name will be published 'in due course'. The HSE added: 'It is expected that the review of individual cases will commence in January. This timeline reflects the complexity of the work involved and the need to ensure a rigorous and comprehensive approach. 'This is a highly complex piece of work that requires sufficient time for planning and preparation. As such the following steps are in progress.' Advertisement The HSE said it had 'engaged meaningfully with patient advocates' and a workshop is being scheduled to progress terms of reference for the review. The Hip Dysplasia Advocacy Group, acting for children who may have undergone unnecessary surgeries, met CHI and HSE officials last Thursday. It said it was told the HSE is aiming for a six-month timeframe for the process. In a statement, it said: 'There has yet to be any correspondence surrounding the retrospective review from the HSE to the families of the children who are potentially affected. Advertisement 'We, the advocacy group, relayed this information to the families immediately post our meeting. Representatives from the Hip Dysplasia Advocacy Group said that this is unacceptable. 'There needs to be full transparency between the HSE and the families regarding these reviews, everyone is left completely in the dark.' Ireland Tánaiste agrees to meet parents of boy who died af... Read More It added that the HSE is yet to confirm the criteria it will use to assess the children's need for surgery. 'A member from the HSE has suggested it will be determined by the expert panel when they are appointed. Advertisement 'We have asked for the HSE to issue an update to all families involved as the lack of correspondence to parents is unacceptable. They have been left in limbo.'

Hospital overcrowding: Over 500 patients without a bed in Irish hospitals
Hospital overcrowding: Over 500 patients without a bed in Irish hospitals

BreakingNews.ie

time4 hours ago

  • BreakingNews.ie

Hospital overcrowding: Over 500 patients without a bed in Irish hospitals

501 people are being treated on trolleys in Irish hospitals on Tuesday, according to the Irish Nurses and Midwives Organisation (INMO). 331 patients are waiting in the emergency department, while 170 are in wards elsewhere in hospitals. Advertisement The hospital with the highest number of people without a bed is University Hospital Limerick with 111 patients on trolleys. 38 people are in the emergency department, with 73 people elsewhere in the hospital. 50 people are without a bed at University Hospital Galway, with 36 patients in the emergency department. At Sligo University Hospital, there are 45 people without a bed, with 24 patients in the emergency department.

Medtronic raises annual profit forecast on lower tariff impact
Medtronic raises annual profit forecast on lower tariff impact

Reuters

time7 hours ago

  • Reuters

Medtronic raises annual profit forecast on lower tariff impact

Aug 19 (Reuters) - Medical-device maker Medtronic (MDT.N), opens new tab raised its fiscal 2026 profit forecast on Tuesday and said it expects a smaller-than-expected impact from the tariffs proposed by U.S. President Donald Trump. The Galway, Ireland-based company expects annual adjusted profit between $5.60 and $5.66 per share, compared with its previous forecast range of $5.50 to $5.60 per share. Investors have high expectations of medical-device makers, as they continue to benefit from healthy demand for non-urgent surgeries - especially among older Americans - over the last few quarters. Medtronic trimmed its assumed tariff impact to be about $185 million for the year, versus a previous range of $200 million to $350 million.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store